Literatur
-
1
Kalow W, Britt B A, Terraeu M E, Haist C.
Metabolic error of muscle metabolism after recovery from malignant hyperthermia.
Lancet.
1970;
ii
895-898
-
2
Ellis F R, Harriman D GF, Keaney N P, Kyei-Mensah K, Tyrrell J H.
Halothane-induced muscle contracture as a cause of hyperpyrexia.
Brit. J. Anaesth..
1971;
43
721-722
-
3
Ellis F R.
The European Malignant Hyperpyrexia Group: A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility.
Brit. J. Anaesth..
1984;
56
1267-1269
-
4
Ørding H, Brancadoro V, Cozzolino S, Ellis F R, Glauber V, Gonano E F, Halsall P J, Hartung E, Heffron J JA, Heytens L, Kozak-Ribbens G, Kress H, Krivosic-Horber R, Lehmann-Horn F, Mortier W, Nivoche Y, Ranklev-Twetman E, Sigurdson S, Snoeck M, Stieglitz P, Tegazzin V, Urwyler A, Wapler F.
In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low-risk subjects.
Acta Anaesthesiol. Scand..
1997;
41
955-966
-
5
Larsen U T, Juhl B, Hein-Sørensen O, Olivarius B F.
Complications during anaesthesia in patients with Duchenne‘s muscular dystrophy (a retrospective study).
Can. J. Anaesth..
1989;
36
418-422
-
6
Heytens L, Martin J J, van de Kelft E, Bossaert L L.
In vitro contracture tests in patients with various neuromuscular diseases.
Brit. J. Anaesth..
1992;
68
72-75
-
7
Lehmann-Horn F, Iaizzo P A.
Are myotonias and periodic paralyses associated with susceptibility to malignant hyperthermia?.
Brit. J. Anaesth..
1990;
65
692-697
-
8
Adnet P J, Krivosic-Horber R M, Krivosic I, Haudecour G, Reyfort H G, Adamantidis M M, Medahoui H.
Viability criterion of muscle bundles used in the in vitro contracture test in patients with neuromuscular diseases.
Brit. J. Anaesth..
1994;
72
93-97
-
9
Wappler F, Scholz J, von Richthofen V, Fiege M, Köchling A, Matschke J, Winkler G, Schulte am Esch J.
Inzidenz der Disposition zur malignen Hyperthermie bei Patienten mit neuromuskulären Erkrankungen.
Anästh. Intensivmed. Notfallmed. Schmerzther..
1998;
33
373-380
-
10
Farrell P T.
Anaesthesia-induced rhabdomyolysis causing cardiac arrest: case report and review of anaesthesia and the dystrophinopathies.
Anaesth. Intens. Care.
1994;
22
597-601
-
11
Boba A.
Fatal postanaesthetic complications in two muscular dystrophic patients.
J. Paediatr. Surg..
1970;
5
71-75
-
12
Tang T T, Oechler H W, Siker D, Segura A D, Franciosi R A.
Anesthesia-induced rhabdomyolysis in infants with unsuspected Duchenne dystrophy.
Acta Paediatr..
1992;
81
716-719
-
13
Chalkiadis G A, Branch K G.
Cardiac arrest after isoflurane anaesthesia in a patient with Duchenne‘s muscular dystrophy.
Anaesthesia.
1990;
45
22-25
-
14
Steinfath M, Scholz J, Singh S, Wappler F.
Welche Bedeutung haben Genotypveränderungen in der Diagnostik der malignen Hyperthermie?.
Anästh. Intensivmed. Notfallmed. Schmerzther..
1996;
31
1-10
-
15
Hopkins P M, Halsall P J, Ellis F R.
Diagnosing malignant hyperthermia susceptibility.
Anaesthesia.
1994;
49
373-375
Dr. Priv.-Doz. Frank Wappler
Klinik für Anästhesiologie
Universitäts-Krankenhaus Eppendorf
Martinistraße 52
D-20246 Hamburg
Email: wappler@uke.uni-hamburg.de
